These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33125094)

  • 1. p53 and ANXA4/NF‑κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma.
    Liu J; Wang H; Zheng M; Deng L; Zhang X; Lin B
    Int J Mol Med; 2020 Dec; 46(6):2102-2114. PubMed ID: 33125094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A4 interacts with the NF-kappaB p50 subunit and modulates NF-kappaB transcriptional activity in a Ca2+-dependent manner.
    Jeon YJ; Kim DH; Jung H; Chung SJ; Chi SW; Cho S; Lee SC; Park BC; Park SG; Bae KH
    Cell Mol Life Sci; 2010 Jul; 67(13):2271-81. PubMed ID: 20237821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
    Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
    Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.
    Mogami T; Yokota N; Asai-Sato M; Yamada R; Koizume S; Sakuma Y; Yoshihara M; Nakamura Y; Takano Y; Hirahara F; Miyagi Y; Miyagi E
    PLoS One; 2013; 8(11):e80359. PubMed ID: 24244679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
    Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
    Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A4 and cancer.
    Wei B; Guo C; Liu S; Sun MZ
    Clin Chim Acta; 2015 Jul; 447():72-8. PubMed ID: 26048190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A4 fucosylation enhances its interaction with the NF-kB p50 and promotes tumor progression of ovarian clear cell carcinoma.
    Wang H; Deng L; Cai M; Zhuang H; Zhu L; Hao Y; Gao J; Liu J; Li X; Lin B
    Oncotarget; 2017 Dec; 8(64):108093-108107. PubMed ID: 29296226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.
    Li L; Zhang R; Liu Y; Zhang G
    DNA Cell Biol; 2020 Sep; 39(9):1649-1656. PubMed ID: 32552056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of RALYL suppresses the progression of ovarian clear cell carcinoma through inhibiting MAPK and CDH1 signaling pathways.
    Xia Y; Ye S; Yang Y; Liu Y; Tong G
    Int J Med Sci; 2021; 18(3):785-791. PubMed ID: 33437214
    [No Abstract]   [Full Text] [Related]  

  • 10. Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arrays.
    Lin LL; Huang HC; Juan HF
    PLoS One; 2012; 7(9):e44615. PubMed ID: 22970268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer.
    Yao HS; Sun C; Li XX; Wang Y; Jin KZ; Zhang XP; Hu ZQ
    Sci Rep; 2016 Aug; 6():31056. PubMed ID: 27491820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of SIRT1 and transcription factor NF-κB (p50/p65) in regulation of porcine ovarian cell function.
    Pavlová S; Klucska K; Vašíček D; Ryban L; Harrath AH; Alwasel SH; Sirotkin AV
    Anim Reprod Sci; 2013 Aug; 140(3-4):180-8. PubMed ID: 23886618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
    Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
    BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.
    Ota Y; Koizume S; Nakamura Y; Yoshihara M; Takahashi T; Sato S; Myoba S; Ohtake N; Kato H; Yokose T; Miyagi E; Miyagi Y
    Oncol Rep; 2021 Mar; 45(3):1023-1032. PubMed ID: 33650653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of annexin A4 in cancer.
    Yao H; Sun C; Hu Z; Wang W
    Front Biosci (Landmark Ed); 2016 Jun; 21(5):949-57. PubMed ID: 27100483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationships between sirtuin 1 and transcription factors p53 and NF-κB (p50/p65) in the control of ovarian cell apoptosis and proliferation.
    Sirotkin AV; Dekanová P; Harrath AH; Alwasel SH; Vašíček D
    Cell Tissue Res; 2014 Nov; 358(2):627-32. PubMed ID: 25027053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers.
    Toyama A; Suzuki A; Shimada T; Aoki C; Aoki Y; Umino Y; Nakamura Y; Aoki D; Sato TA
    Cancer Sci; 2012 Apr; 103(4):747-55. PubMed ID: 22321069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma.
    Oishi T; Itamochi H; Kudoh A; Nonaka M; Kato M; Nishimura M; Oumi N; Sato S; Naniwa J; Sato S; Shimada M; Kigawa J; Harada T
    Oncol Rep; 2014 Aug; 32(2):553-8. PubMed ID: 24927217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANXA4 promotes trophoblast invasion via the PI3K/Akt/eNOS pathway in preeclampsia.
    Xu Y; Sui L; Qiu B; Yin X; Liu J; Zhang X
    Am J Physiol Cell Physiol; 2019 Apr; 316(4):C481-C491. PubMed ID: 30673304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.
    Mehner C; Miller E; Hockla A; Coban M; Weroha SJ; Radisky DC; Radisky ES
    Oncogene; 2020 Oct; 39(42):6606-6618. PubMed ID: 32929152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.